drugset / Trial / NCT00605085
Safety and Tolerability of the Japanese Encephalitis Vaccine IC51
RandomizedParallel-groupDouble-blindPrevention
Summary
The objective is to investigate the safety and tolerability of Japanese Encephalitis vaccine IC51 with an inactive control in healthy subjects aged \> or = 18 years
Timeline
- Start
- 2005-10
- Primary completion
- —
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IC51 | Vaccine | 6 ug | Intramuscular |